Damon Jack

687 total citations
8 papers, 548 citations indexed

About

Damon Jack is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Infectious Diseases. According to data from OpenAlex, Damon Jack has authored 8 papers receiving a total of 548 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 0 papers in Infectious Diseases. Recurrent topics in Damon Jack's work include Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Asthma and respiratory diseases (8 papers) and Respiratory Support and Mechanisms (5 papers). Damon Jack is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (8 papers), Asthma and respiratory diseases (8 papers) and Respiratory Support and Mechanisms (5 papers). Damon Jack collaborates with scholars based in United States, United Kingdom and Germany. Damon Jack's co-authors include Mark Higgins, Roger Owen, Benjamin Krämer, H Magnussen, Simon Piggott, Kian Fan Chung, В Е Ноников, Ronald Dahl, Roland Buhl and Pascal Chanez and has published in prestigious journals such as CHEST Journal, Thorax and Respiratory Medicine.

In The Last Decade

Damon Jack

8 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Damon Jack United States	6	512	470	19	15	15	8	548
В Е Ноников Russia	3	472 0.9×	401 0.9×	14 0.7×	9 0.6×	6 0.4×	5	494
Thomas M. Siler United States	10	501 1.0×	381 0.8×	14 0.7×	31 2.1×	2 0.1×	24	549
Joseph Aumann Belgium	10	490 1.0×	407 0.9×	21 1.1×	15 1.0×	2 0.1×	18	523
R Abrahams United States	7	513 1.0×	424 0.9×	23 1.2×	3 0.2×	4 0.3×	23	529
Jan Verhaert Belgium	5	495 1.0×	413 0.9×	19 1.0×	9 0.6×		6	526
Michelle Henley United States	8	594 1.2×	465 1.0×	25 1.3×	3 0.2×	5 0.3×	14	614
Piet J.G. Cornelissen Netherlands	7	317 0.6×	281 0.6×	4 0.2×	14 0.9×	5 0.3×	8	335
Anna Unseld Germany	9	297 0.6×	371 0.8×	9 0.5×	59 3.9×	5 0.3×	19	499
Danny McBryan Switzerland	6	300 0.6×	231 0.5×	7 0.4×	6 0.4×		7	311
Liam Polley United Kingdom	4	255 0.5×	244 0.5×	3 0.2×	18 1.2×		7	332

Countries citing papers authored by Damon Jack

Since Specialization

Citations

This map shows the geographic impact of Damon Jack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damon Jack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damon Jack more than expected).

Fields of papers citing papers by Damon Jack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damon Jack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damon Jack. The network helps show where Damon Jack may publish in the future.

Co-authorship network of co-authors of Damon Jack

This figure shows the co-authorship network connecting the top 25 collaborators of Damon Jack. A scholar is included among the top collaborators of Damon Jack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damon Jack. Damon Jack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Vincken, Walter, et al.. (2013). P232 Once-daily co-administration of glycopyrronium and indacaterol via Breezhaler^®device improves lung function and symptoms in patients with COPD versus indacaterol alone: the GLOW6 study. Thorax. 68(Suppl 3). A181.2–A182. 2 indexed citations

2.

Magnussen, H, C. Verkindre, Damon Jack, et al.. (2010). Indacaterol once-daily is equally effective dosed in the evening or morning in COPD. Respiratory Medicine. 104(12). 1869–1876. 23 indexed citations

3.

Feldman, Gregory, Thomas M. Siler, Damon Jack, et al.. (2010). Efficacy and safety of indacaterol 150 μg once-daily in COPD: a double-blind, randomised, 12-week study. BMC Pulmonary Medicine. 10(1). 11–11. 101 indexed citations

4.

Dahl, Ronald, Kian Fan Chung, Roland Buhl, et al.. (2010). Efficacy of a new once-daily long-acting inhaled 2-agonist indacaterol versus twice-daily formoterol in COPD. Thorax. 65(6). 473–479. 213 indexed citations

5.

Vogelmeier, Claus, David Ramos‐Barbón, Damon Jack, et al.. (2010). Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium. Respiratory Research. 11(1). 135–135. 66 indexed citations

6.

Vogelmeier, Claus, David Ramos‐Barbón, Damon Jack, et al.. (2009). ONCE-DAILY INDACATEROL PROVIDES EFFECTIVE 24-HOUR BRONCHODILATION IN COPD: A DOUBLE-BLIND COMPARISON WITH TIOTROPIUM. CHEST Journal. 136(4). 4S–4S. 5 indexed citations

7.

Rennard, Stephen I., Theo A. Bantje, Stefano Centanni, et al.. (2008). A dose-ranging study of indacaterol in obstructive airways disease, with a tiotropium comparison. Respiratory Medicine. 102(7). 1033–1044. 71 indexed citations

8.

Beier, Jutta, Pascal Chanez, Jean‐Benoît Martinot, et al.. (2006). Safety, tolerability and efficacy of indacaterol, a novel once-daily β2-agonist, in patients with COPD: A 28-day randomised, placebo controlled clinical trial. Pulmonary Pharmacology & Therapeutics. 20(6). 740–749. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact